We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$27.2M
2
AMZN icon
Amazon
AMZN
+$19.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.8M
4
EAT icon
Brinker International
EAT
+$15.8M
5
APD icon
Air Products & Chemicals
APD
+$15.1M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSH
626
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
– –
-12,327
Closed -$525K
UFS
627
DELISTED
DOMTAR CORPORATION (New)
UFS
– –
-9,425
Closed -$330K
DEG
628
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
– –
-53,819
Closed -$1.41M
22 23 24 25
26

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.